Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A 1 to 1000 SARS-CoV-2 reinfection proportion in members of a large healthcare provider in Israel: a preliminary report

Galit Perez, Tamar Banon, Sivan Gazit, Shay Ben Moshe, Joshua Wortsman, Daniel Grupel, Asaf Peretz, Amir Ben Tov, Gabriel Chodick, Miri Mizrahi-Reuveni, Tal Patalon
doi: https://doi.org/10.1101/2021.03.06.21253051
Galit Perez
1Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: perez_g@mac.org.il
Tamar Banon
2Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sivan Gazit
1Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shay Ben Moshe
3Ben-Gurion University, Beer Sheva, Israel
1Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joshua Wortsman
1Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Grupel
3Ben-Gurion University, Beer Sheva, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Asaf Peretz
4Internal Medicine COVID-19 Ward, Samson Assuta Ashdod University Hospital, Ashdod Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amir Ben Tov
2Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel
5Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriel Chodick
2Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel
5Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miri Mizrahi-Reuveni
6Health Division, Maccabi Healthcare Services, Tel Aviv, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tal Patalon
2Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

With more than 100 million confirmed COVID-19 cases as of March 2021, reinfection is still considered to be rare. In light of increasing reports of reinfected COVID-19 patients, the need to better understand the real risk for reinfection is critical, with potential effects on public health policies aimed at containing the spread of SARS-CoV-2. In this descriptive preliminary report, we conducted a large-scale assessment on the country level of the possible occurrence of COVID-19 reinfection within the members of a large healthcare provider in Israel. Out of 149,735 individuals with a documented positive PCR test between March 2020 and January 2021, 154 had two positive PCR tests at least 100 days apart, reflecting a reinfection proportion of 1 per 1000. Given our strict inclusion criteria, we believe these numbers represent true reinfection incidence in MHS and should be clinically regarded as such.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding was received for this study

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Maccabi health care services IRB, Israel

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

This retrospective study was conducted using data from the Maccabi Healthcare Services (MHS) central computerized database, the second largest state-mandated not-for-profit healthcare provider in Israel, containing more than 2.5 million members (approximately 25% of the population) and is a representative sample of the Israeli population. This fully computerized database captures all information on patient interaction (including demographics, visits, diagnoses, procedures and more). The data is made accessible by MHS Research and Innovation Center under the MHS institutional review board guidelines and approval.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted March 08, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A 1 to 1000 SARS-CoV-2 reinfection proportion in members of a large healthcare provider in Israel: a preliminary report
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A 1 to 1000 SARS-CoV-2 reinfection proportion in members of a large healthcare provider in Israel: a preliminary report
Galit Perez, Tamar Banon, Sivan Gazit, Shay Ben Moshe, Joshua Wortsman, Daniel Grupel, Asaf Peretz, Amir Ben Tov, Gabriel Chodick, Miri Mizrahi-Reuveni, Tal Patalon
medRxiv 2021.03.06.21253051; doi: https://doi.org/10.1101/2021.03.06.21253051
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
A 1 to 1000 SARS-CoV-2 reinfection proportion in members of a large healthcare provider in Israel: a preliminary report
Galit Perez, Tamar Banon, Sivan Gazit, Shay Ben Moshe, Joshua Wortsman, Daniel Grupel, Asaf Peretz, Amir Ben Tov, Gabriel Chodick, Miri Mizrahi-Reuveni, Tal Patalon
medRxiv 2021.03.06.21253051; doi: https://doi.org/10.1101/2021.03.06.21253051

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (230)
  • Allergy and Immunology (507)
  • Anesthesia (111)
  • Cardiovascular Medicine (1264)
  • Dentistry and Oral Medicine (207)
  • Dermatology (148)
  • Emergency Medicine (283)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (538)
  • Epidemiology (10056)
  • Forensic Medicine (5)
  • Gastroenterology (502)
  • Genetic and Genomic Medicine (2486)
  • Geriatric Medicine (240)
  • Health Economics (482)
  • Health Informatics (1653)
  • Health Policy (757)
  • Health Systems and Quality Improvement (638)
  • Hematology (250)
  • HIV/AIDS (538)
  • Infectious Diseases (except HIV/AIDS) (11896)
  • Intensive Care and Critical Care Medicine (627)
  • Medical Education (255)
  • Medical Ethics (75)
  • Nephrology (269)
  • Neurology (2304)
  • Nursing (140)
  • Nutrition (354)
  • Obstetrics and Gynecology (458)
  • Occupational and Environmental Health (537)
  • Oncology (1259)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (326)
  • Pediatrics (737)
  • Pharmacology and Therapeutics (315)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2295)
  • Public and Global Health (4850)
  • Radiology and Imaging (846)
  • Rehabilitation Medicine and Physical Therapy (493)
  • Respiratory Medicine (657)
  • Rheumatology (289)
  • Sexual and Reproductive Health (241)
  • Sports Medicine (228)
  • Surgery (273)
  • Toxicology (44)
  • Transplantation (131)
  • Urology (100)